Aartech Solonics Limited is a research and development enterprise in India that focuses on providing system solutions for specialized energy appliances. The company specializes in manufacturing electricity distribution and control apparatus, including switches, fuses, voltage limiters, surge suppressors, junction boxes, relays, sockets, boards, panels, consoles, cabinets, and other bases for electricity control or distribution. Additionally, Aartech Solonics Limited offers a range of products such as the BTS 2000 fast bus transfer system, ultra-capacitors, control relay panels, load checkers, current limiting protectors, Bestcase enclosures, organic waste to compost machines, and backlit photo frames. The company caters to various industries including renewable and non-renewable energy, power transmission and distribution, heavy engineering, defense and exploration, healthcare, IT & Telecom, and transportation. Aartech Solonics Limited was established in 1982 and is headquartered in Bhopal, India.
Navigation section
Aarti Drugs Limited
- 520.00 -5.30(-1.01%) 520.85 -4.00(-0.76%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 517.15 517.30 | 529.70 529.90 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 431.05 (28-Mar-2024) 430.00 (28-Mar-2024) | 635.00 (27-Aug-2024) 634.90 (27-Aug-2024) |
- Open
- 526.90 529.90
- Previous Close
- 525.30 524.85
- Volume
- 1.04
- Total Traded value
- 5.42 (₹ Lakhs)
- Upper circuit
- 630.35 621.90
- Lower circuit
- 420.25 414.60
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 1,201 | 0 |
| Bid Price | Quantity |
|---|---|
| 518.60 | 1,201.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 1,201 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹47.81 Cr |
| PE Ratio (TTM): | 37.33 |
| PB Ratio: | 4.11 |
| Industry P/E: | 30.78 |
| Debt to Equity: | - |
| ROE: | 11.00 |
| EPS (TTM): | 14.06 |
| Book Value: | 121.27 |
| Face Value: | 10.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 577.54 Cr | 591.63 Cr | 696.41 Cr | 625.53 Cr | 624.83 Cr |
| Profit | 34.58 Cr | 39.54 Cr | 53.17 Cr | 36.71 Cr | 36.58 Cr |
| Expense | 531.45 Cr | 539.24 Cr | 627.92 Cr | 577.54 Cr | 574.84 Cr |
| Comprehensive income | 34.58 Cr | 39.54 Cr | 51.75 Cr | 36.71 Cr | 36.58 Cr |
| EPS | 3.75 | 4.27 | 5.74 | 3.96 | 3.95 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Aarti Drugs Limited | Sep, 2003 Sep, 1993 | Pharmaceuticals Pharmaceuticals | AARTIDRUGS AARTIDRUGS |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Aarti Drugs Limited FAQ's
What is the range of today's stock performance for Aarti Drugs Limited?
Today's stock performance witnessed a fluctuation from a minimum of 517.15 on the NSE (National Stock Exchange) to a maximum of 529.70. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 517.30 to a high of 529.90.
What are the 52-week low and high values for Aarti Drugs Limited?
The stock's performance over the past 52 weeks reveals a low of 431.05 (occurred on 28-Mar-2024) and a high of 635.00 (achieved on 27-Aug-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 430.00 (on 28-Mar-2024), and the 52-week high is 634.90 (on 27-Aug-2024).
What was the opening and previous closing prices for Aarti Drugs Limited?
The stock's performance over the past 52 weeks reveals a low of 431.05 (occurred on 28-Mar-2024) and a high of 635.00 (achieved on 27-Aug-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 430.00 (on 28-Mar-2024), and the 52-week high is 634.90 (on 27-Aug-2024).
What is the total volume and traded value for Aarti Drugs Limited for the day?
The total volume is 1, and the total traded value is 5.42 (₹ Lakhs).
What are the upper and lower circuit limits for Aarti Drugs Limited?
The upper circuit limit is 630.35, and the lower circuit limit is 420.25.
What is the market cap and PE ratio for Aarti Drugs Limited?
The market cap is ₹47.81 Cr, and the PE ratio (TTM) is 30.78.
What is the PB ratio, industry P/E, and debt to equity ratio for Aarti Drugs Limited?
The PB ratio is 4.29, industry P/E is 30.78 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Aarti Drugs Limited?
ROE is 11.00, EPS is 14.06, book value is 121.27
What are the revenue and profit figures for the latest quarter and previous quarters for Aarti Drugs Limited?
In Sep 2023, Revenue is ₹5775400000.00, and Profit is ₹345800000.00. In Jun 2023, Revenue is ₹5916300000.00, and Profit is ₹395400000.00.
When was Aarti Drugs Limited listed, and what industry does it belong to?
The company, Aarti Drugs Limited, was listed in Sep 2003 and belongs to the Pharmaceuticals industry. Its NSE symbol is AARTIDRUGS.
What is the current shareholding pattern of the Aarti Drugs Limited?
As of latest available update, promoters hold 58.56%, the public holds 41.44%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 18
- Threads
- 32
Latest Business News
Apple will start selling iPhone 16 series from September 20, Pro model for Rs 1,19,900New Delhi: Premium mobile device maker Apple will start selling iPhone 16 series smartphones...- NewsBot
- Updated:
-
SEBI bars Axis Capital from taking up new loan merchant banking workNew Delhi, Markets regulator Sebi on Thursday restrained Axis Capital from taking up new...
- NewsBot
- Updated:
-
Combined value of top 75 brands rises 19% to $450.5 billion, TCS tops charts: Kantar Brandz ReportNew Delhi: The combined valuation of India's 75 most valuable brands has risen at an "impressive...
- NewsBot
- Updated:
-
UK fintech Revolut prepares to launch in India in 2025London, UK-based fintech major Revolut is gearing up to launch in India next year following...
- NewsBot
- Updated:
-
Rupee rises 11 paise to close at 83.65 against US dollarMumbai rupee strengthened by 11 paise to hit a two-month high of 83.65 against the US dollar on...
- NewsBot
- Updated: